Production (Stage)
HOOKIPA Pharma Inc.
HOOK
$1.53
-$0.03-1.92%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.00M | 1.35M | 4.70M | 1.29M | 36.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.00M | 1.35M | 4.70M | 1.29M | 36.60M |
| Cost of Revenue | 12.86M | 11.65M | 15.57M | 156.00K | 20.17M |
| Gross Profit | -10.86M | -10.30M | -10.86M | 1.13M | 16.43M |
| SG&A Expenses | 6.89M | 6.87M | 6.73M | 3.95M | 4.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.75M | 18.52M | 22.30M | 23.69M | 24.22M |
| Operating Income | -17.74M | -17.16M | -17.59M | -22.40M | 12.38M |
| Income Before Tax | -15.43M | -25.06M | -13.84M | -19.10M | 14.38M |
| Income Tax Expenses | -- | -106.00K | -- | -- | -- |
| Earnings from Continuing Operations | -15.43M | -24.95M | -13.84M | -19.10M | 14.38M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.43M | -24.95M | -13.84M | -19.10M | 14.38M |
| EBIT | -17.74M | -17.16M | -17.59M | -22.40M | 12.38M |
| EBITDA | -17.35M | -16.47M | -16.89M | -21.69M | 13.02M |
| EPS Basic | -1.23 | -1.99 | -1.10 | -1.52 | 1.14 |
| Normalized Basic EPS | -0.76 | -1.03 | -0.64 | -0.95 | 0.78 |
| EPS Diluted | -1.23 | -1.99 | -1.10 | -1.52 | 1.14 |
| Normalized Diluted EPS | -0.76 | -1.03 | -0.64 | -0.95 | 0.78 |
| Average Basic Shares Outstanding | 12.54M | 12.54M | 12.54M | 12.54M | 12.60M |
| Average Diluted Shares Outstanding | 12.54M | 12.54M | 12.54M | 12.54M | 12.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |